E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/27/2013 in the Prospect News High Yield Daily.

New Issue: Valeant Pharmaceuticals prices $3.225 billion notes in two tranches

By Paul A. Harris

Portland, Ore., June 27 - Valeant Pharmaceuticals International, Inc. priced $3,225,000,000 of senior notes (B1/B) in two tranches on Thursday, according to market sources.

The deal included a $1.6 billion tranche of five-year notes that priced at par to yield 6¾%. The yield printed on top of yield talk.

In addition, the company priced a $1,625,000,000 tranche of eight-year notes at par to yield 7½%.

The yield printed on top of yield talk. The initial guidance was in the mid-6% range.

A proposed tranche of 10-year notes was withdrawn.

Goldman Sachs & Co. was the left bookrunner for the Rule 144A for life deal. BofA Merrill Lynch, Barclays, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and RBC Capital Markets are the joint bookrunners.

The issuing entity will be VPII Escrow Corp., a newly formed, wholly owned Canadian subsidiary of Valeant Pharmaceuticals International.

Proceeds will be used to help finance the acquisition of Bausch + Lomb.

Valeant is a Laval, Quebec-based specialty pharmaceutical company. Bausch + Lomb is a Rochester, N.Y.-based eye health company.

Issuer:VPII Escrow Corp.
Amount:$3,225,000,000
Securities:Senior notes
Left bookrunner:Goldman Sachs & Co.
Joint bookrunners:BofA Merrill Lynch, Barclays, J.P. Morgan Securities, LLC, Morgan Stanley & Co. LLC, RBC Capital Markets
Co-managers:DNB Markets, SunTrust Robinson Humphrey, HSBC, Mitsubishi UFJ, TD Securities
Trade date:June 27
Settlement date:July 12
Ratings:Moody's: B1
Standard & Poor's: B
Distribution:Rule 144A and Regulation S for life
Marketing:Roadshow
Five-year notes
Amount:$1.6 billion
Maturity:Aug. 15, 2018
Coupon:6¾%
Price:Par
Yield:6¾%
Spread:529 bps
Call protection:Two years
Price talk:6¾% area
Eight-year notes
Amount:$1,625,000,000
Maturity:July 15, 2021
Coupon:7½%
Price:Par
Yield:7½%
Spread:531 bps
Call protection:Three years
Price talk:7½% area

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.